French stock alert

FRA

CLOSING UPDATE: Sanofi decreases 0.8%, led market lower 17 October 2017 18:10 CEST

NEWS BITES - EUROPE

This is an end of day Alert, produced after today's French market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Sanofi, France's largest pharmaceuticals & biotechnology company by market capitalisation, has decreased 0.8% to trade at EUR83.89 vs. the CAC 40 Index which weakened 1.5 points (or 0.03%) to 5,361.4. Representing a weighting of about 7.2% of the index, the stock accounted for the loss. Trading volume was 49% of average at the end of the day. Compared with the CAC 40 Index which fell 1.5 points (or 0.03%) in the day, this represented a relative price change of -0.7%.

Technical indicators complementing today's significant downtrend:

+ The price decreased 1.0% in the last week.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

+ Price/Earnings/Growth of 1.66 [1.4]

+ Return on Equity 7.4% [14.8%]

+ Return on Assets 4.2% [5.9%]

+ Return on Capital Employed 6.4% [9.2%]

Other Bearish Signals include:

+ Net profit margin has averaged 13.2% in the last 3 years. This is lower than the sector average of 16% and suggests a low margin of safety.

+ As per the Du Pont analysis, Return on Equity is less than stellar at 7.4%. Also, this has deteriorated from 7.6% last year.

Note

Sanofi today is at a discount of 9.8% to the 12-month high of EUR92.97 on 15 May, 2017. It is at a premium of 24.8% to the 12-month low of EUR67.22 on 26 Oct, 2016.

Bullish Signals:

The positive 0.41 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

Tobin's Q Ratio is 1. Compared with the rest of the market the stock is undervalued.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

Price/Earnings of 20.7 [24.7]

Price/Sales of 3 [3.8]

Year-on-Year Earnings Growth of 24.7% [18.0%]

TODAY'S ALERTS

Afternoon Alert: Sanofi decreases 0.5%, leads Pharmaceuticals & biotechnology sector lower

17 October 2017 14:11 CEST

Sanofi (FR:SAN) has decreased 0.5% to trade at EUR84.12 vs. the Pharmaceuticals & biotechnology sector which weakened 22.4 points (or 0.2%) to 10,968.0. Representing a weighting of about 29.2% of the sector, the stock accounted for 72.6% of today's loss. Trading volume was 78% of average so far today.

Afternoon Alert: Sanofi decreases 0.5%, leads market lower

17 October 2017 12:16 CEST

Sanofi (FR:SAN) has decreased 0.5% to trade at EUR84.08 vs. the CAC 40 Index which weakened 3.5 points (or 0.07%) to 5,359.4. Representing a weighting of about 7.2% of the index, the stock accounted for 56.2% of today's loss. Trading volume was 80% of average so far today.

RECENT ALERTS

CLOSING UPDATE: Sanofi increases a further 0.2%, led market higher

16 October 2017 18:08 CEST

Sanofi, France's largest pharmaceuticals & biotechnology company by market capitalisation, has increased 1.1% to trade at EUR84.54 vs. the CAC 40 Index which strengthened 11.1 points (or 0.2%) to 5,362.9. Representing a weighting of about 7.3% of the index, the stock accounted for 38.9% of today's gain. Trading volume was 43% of average at the end of the day. Compared with the CAC 40 Index which rose 11.1 points (or 0.2%) in the day, this represented a relative price increase of 0.9%.

Afternoon Alert: Sanofi increases 1.0%, leads market higher

16 October 2017 14:02 CEST

Sanofi (FR:SAN) has increased 1.0% to trade at EUR84.40 vs. the CAC 40 Index which strengthened 5.2 points (or 0.1%) to 5,356.9. Representing a weighting of about 7.3% of the index, the stock accounted for 69.4% of today's gain. Trading volume was 69% of average so far today.

Sanofi (FR:SAN; EPA:SAN; PA:SAN; FP:SAN)

ISIN: FR0000120578

PermID: 4296871638

Source: www.BuySellSignals.com